DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $573,244,726 | +73.7% | 2,310,539 | +68.0% | 0.12% | +80.9% |
| Q2 2023 | $330,008,640 | +3.3% | 1,375,036 | +8.5% | 0.07% | -4.2% |
| Q1 2023 | $319,358,876 | -2.1% | 1,267,096 | +3.1% | 0.07% | -6.6% |
| Q4 2022 | $326,144,115 | -28.8% | 1,228,785 | -30.7% | 0.08% | -26.9% |
| Q3 2022 | $458,117,000 | +36.1% | 1,773,654 | +33.6% | 0.10% | +20.9% |
| Q2 2022 | $336,509,000 | -39.3% | 1,327,347 | -29.8% | 0.09% | -24.6% |
| Q1 2022 | $554,332,000 | -15.1% | 1,889,788 | -4.8% | 0.11% | -14.3% |
| Q4 2021 | $652,866,000 | +8.7% | 1,984,335 | +0.6% | 0.13% | +6.4% |
| Q3 2021 | $600,434,000 | +72.9% | 1,972,258 | +52.4% | 0.12% | +62.3% |
| Q2 2021 | $347,254,000 | -20.5% | 1,293,983 | -33.3% | 0.08% | -28.0% |
| Q1 2021 | $436,541,000 | +5.2% | 1,939,492 | +3.8% | 0.11% | 0.0% |
| Q4 2020 | $415,087,000 | +51.0% | 1,868,584 | +46.4% | 0.11% | +37.2% |
| Q3 2020 | $274,859,000 | -19.8% | 1,276,457 | -34.1% | 0.08% | -36.6% |
| Q2 2020 | $342,646,000 | +0.8% | 1,937,706 | -21.1% | 0.12% | -19.1% |
| Q1 2020 | $339,873,000 | +534.9% | 2,455,553 | +604.0% | 0.15% | +560.9% |
| Q4 2019 | $53,531,000 | +1.4% | 348,785 | -4.6% | 0.02% | -8.0% |
| Q3 2019 | $52,807,000 | -8.7% | 365,626 | -9.7% | 0.02% | -3.8% |
| Q2 2019 | $57,862,000 | -39.7% | 404,855 | -44.3% | 0.03% | -45.8% |
| Q1 2019 | $96,034,000 | -11.1% | 727,426 | -30.6% | 0.05% | -20.0% |
| Q4 2018 | $108,015,000 | +354.4% | 1,047,467 | +378.8% | 0.06% | +445.5% |
| Q3 2018 | $23,772,000 | -56.0% | 218,773 | -60.0% | 0.01% | -59.3% |
| Q2 2018 | $53,998,000 | -65.8% | 547,199 | -66.1% | 0.03% | -69.0% |
| Q1 2018 | $157,871,000 | +116.8% | 1,612,419 | +105.6% | 0.09% | +93.3% |
| Q4 2017 | $72,803,000 | -64.7% | 784,352 | -67.4% | 0.04% | -71.5% |
| Q3 2017 | $206,251,000 | +323.1% | 2,404,421 | +316.3% | 0.16% | +276.2% |
| Q2 2017 | $48,748,000 | +168.2% | 577,632 | +171.8% | 0.04% | +162.5% |
| Q1 2017 | $18,179,000 | -89.2% | 212,544 | -90.2% | 0.02% | -90.6% |
| Q4 2016 | $168,519,000 | +1038.6% | 2,164,939 | +1046.6% | 0.17% | +1040.0% |
| Q3 2016 | $14,800,000 | -89.1% | 188,808 | -86.0% | 0.02% | -90.1% |
| Q2 2016 | $135,752,000 | -36.9% | 1,344,072 | -40.7% | 0.15% | -44.3% |
| Q1 2016 | $215,063,000 | +27.1% | 2,267,165 | +24.5% | 0.27% | +46.5% |
| Q4 2015 | $169,151,000 | +25.8% | 1,821,179 | +15.4% | 0.18% | +44.5% |
| Q3 2015 | $134,451,000 | +197.8% | 1,577,882 | +199.1% | 0.13% | +228.2% |
| Q2 2015 | $45,146,000 | -82.5% | 527,467 | -82.7% | 0.04% | -84.1% |
| Q1 2015 | $258,570,000 | -7.4% | 3,045,574 | -6.5% | 0.24% | -10.6% |
| Q4 2014 | $279,184,000 | -31.0% | 3,257,302 | -38.8% | 0.27% | -35.2% |
| Q3 2014 | $404,435,000 | +16.3% | 5,322,915 | +20.5% | 0.42% | +6.3% |
| Q2 2014 | $347,658,000 | +95.1% | 4,415,825 | +85.9% | 0.40% | +90.4% |
| Q1 2014 | $178,199,000 | +0.5% | 2,375,994 | +3.5% | 0.21% | -9.5% |
| Q4 2013 | $177,266,000 | -14.3% | 2,296,186 | -23.1% | 0.23% | -26.7% |
| Q3 2013 | $206,873,000 | +98.7% | 2,984,314 | +81.4% | 0.32% | +76.0% |
| Q2 2013 | $104,113,000 | – | 1,644,748 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |